

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | blood coagulation, intrinsic pathway (GO:0007597) | 5.72157510 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07238484 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 4.63397323 |
| 4 | regulation of lipoprotein metabolic process (GO:0050746) | 4.37554566 |
| 5 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.91224698 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.91208857 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 3.91208857 |
| 8 | regulation of platelet aggregation (GO:0090330) | 3.81449093 |
| 9 | oxygen transport (GO:0015671) | 3.80480758 |
| 10 | regulation of platelet activation (GO:0010543) | 3.77453645 |
| 11 | gas transport (GO:0015669) | 3.74127279 |
| 12 | positive regulation of blood coagulation (GO:0030194) | 3.73362499 |
| 13 | positive regulation of hemostasis (GO:1900048) | 3.73362499 |
| 14 | exogenous drug catabolic process (GO:0042738) | 3.72095681 |
| 15 | low-density lipoprotein particle remodeling (GO:0034374) | 3.62952357 |
| 16 | fibrinolysis (GO:0042730) | 3.58459717 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51519578 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.50355955 |
| 19 | drug catabolic process (GO:0042737) | 3.50213018 |
| 20 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.47901433 |
| 21 | reverse cholesterol transport (GO:0043691) | 3.47030921 |
| 22 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.44213846 |
| 23 | positive regulation of coagulation (GO:0050820) | 3.41447434 |
| 24 | adenosine receptor signaling pathway (GO:0001973) | 3.29687626 |
| 25 | protein neddylation (GO:0045116) | 3.26779634 |
| 26 | negative regulation of protein localization to cell surface (GO:2000009) | 3.24779933 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 3.24106360 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.22232802 |
| 29 | protein carboxylation (GO:0018214) | 3.22232802 |
| 30 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.20262514 |
| 31 | negative regulation of norepinephrine secretion (GO:0010700) | 3.18141850 |
| 32 | regulation of female receptivity (GO:0045924) | 3.17144127 |
| 33 | negative regulation of blood coagulation (GO:0030195) | 3.16588102 |
| 34 | negative regulation of hemostasis (GO:1900047) | 3.16588102 |
| 35 | negative regulation of platelet activation (GO:0010544) | 3.13158675 |
| 36 | angiogenesis involved in wound healing (GO:0060055) | 3.10549735 |
| 37 | platelet aggregation (GO:0070527) | 3.09526441 |
| 38 | ethanol oxidation (GO:0006069) | 3.09329170 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.06372349 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.06372349 |
| 41 | negative regulation of heart rate (GO:0010459) | 3.01272536 |
| 42 | negative regulation of appetite (GO:0032099) | 3.00752856 |
| 43 | negative regulation of response to food (GO:0032096) | 3.00752856 |
| 44 | autophagic vacuole fusion (GO:0000046) | 2.99933996 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 2.97625589 |
| 46 | phospholipid homeostasis (GO:0055091) | 2.96126568 |
| 47 | regulation of protein activation cascade (GO:2000257) | 2.92757813 |
| 48 | regulation of complement activation (GO:0030449) | 2.87535673 |
| 49 | regulation of hemostasis (GO:1900046) | 2.85210869 |
| 50 | regulation of blood coagulation (GO:0030193) | 2.85210869 |
| 51 | tyrosine metabolic process (GO:0006570) | 2.83894624 |
| 52 | platelet degranulation (GO:0002576) | 2.82666128 |
| 53 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.81429017 |
| 54 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.80349381 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 2.77368185 |
| 56 | macromolecular complex remodeling (GO:0034367) | 2.77368185 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 2.77368185 |
| 58 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.75790227 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 2.75438024 |
| 60 | negative regulation of coagulation (GO:0050819) | 2.73801723 |
| 61 | protein activation cascade (GO:0072376) | 2.72440864 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 2.71605035 |
| 63 | female mating behavior (GO:0060180) | 2.69696267 |
| 64 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.67461761 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 2.66091984 |
| 66 | acylglycerol homeostasis (GO:0055090) | 2.63394296 |
| 67 | triglyceride homeostasis (GO:0070328) | 2.63394296 |
| 68 | regulation of endothelial cell differentiation (GO:0045601) | 2.59733447 |
| 69 | complement activation, alternative pathway (GO:0006957) | 2.58602579 |
| 70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55611470 |
| 71 | regulation of coagulation (GO:0050818) | 2.54985401 |
| 72 | hemoglobin metabolic process (GO:0020027) | 2.53306871 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 2.53227975 |
| 74 | amine catabolic process (GO:0009310) | 2.53227975 |
| 75 | negative regulation of wound healing (GO:0061045) | 2.53143988 |
| 76 | negative regulation of heart contraction (GO:0045822) | 2.50699553 |
| 77 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.49969521 |
| 78 | bile acid and bile salt transport (GO:0015721) | 2.49126044 |
| 79 | dopamine transport (GO:0015872) | 2.46395408 |
| 80 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.41061629 |
| 81 | megakaryocyte development (GO:0035855) | 2.39993294 |
| 82 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.39967143 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 2.39799551 |
| 84 | positive regulation of wound healing (GO:0090303) | 2.39572445 |
| 85 | ethanol metabolic process (GO:0006067) | 2.39552052 |
| 86 | negative regulation of protein activation cascade (GO:2000258) | 2.35087011 |
| 87 | axon ensheathment in central nervous system (GO:0032291) | 2.34398245 |
| 88 | central nervous system myelination (GO:0022010) | 2.34398245 |
| 89 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.33527474 |
| 90 | regulation of norepinephrine secretion (GO:0014061) | 2.33038496 |
| 91 | extracellular fibril organization (GO:0043206) | 2.32956008 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.32067834 |
| 93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.32067834 |
| 94 | platelet activation (GO:0030168) | 2.31394017 |
| 95 | omega-hydroxylase P450 pathway (GO:0097267) | 2.31229782 |
| 96 | lipoxygenase pathway (GO:0019372) | 2.30423384 |
| 97 | S-adenosylmethionine metabolic process (GO:0046500) | 2.29765644 |
| 98 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.29264810 |
| 99 | drug metabolic process (GO:0017144) | 2.28196045 |
| 100 | negative regulation of complement activation (GO:0045916) | 2.27903370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.33219409 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.16104732 |
| 3 | GATA1_19941826_ChIP-Seq_K562_Human | 2.78298919 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 2.62987594 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52580038 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49711403 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.10761560 |
| 8 | GATA2_19941826_ChIP-Seq_K562_Human | 2.08660196 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.07193290 |
| 10 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.04869557 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.99149911 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84556113 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82608057 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81865503 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77564348 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72807157 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64564703 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59036453 |
| 19 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55003681 |
| 20 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51613447 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51166346 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48324259 |
| 23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46274387 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42023377 |
| 25 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.40983069 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33271920 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31379066 |
| 28 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25393708 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24794947 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24781161 |
| 31 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23332131 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19774455 |
| 33 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16769907 |
| 34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14853758 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14352930 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12877341 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11752202 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10539441 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10300557 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10072962 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07856101 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07264513 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06945547 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05802795 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04720004 |
| 46 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.02946080 |
| 47 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.01935742 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00757087 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99981113 |
| 50 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99698273 |
| 51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98548395 |
| 52 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97937365 |
| 53 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95189070 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94840408 |
| 55 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94840408 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94710461 |
| 57 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94512924 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94344206 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93898818 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93645146 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93399844 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93362521 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92015805 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90755268 |
| 65 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.90503830 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89656745 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89526921 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89166834 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88754295 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85393491 |
| 71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84806296 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84713639 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83973804 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83728066 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81525851 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.78773756 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78705818 |
| 78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.78645603 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78550996 |
| 80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78024333 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77691340 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77491764 |
| 83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.77338003 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74752083 |
| 85 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.74701198 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.74291198 |
| 87 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73461429 |
| 88 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73072052 |
| 89 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.72439399 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72123005 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71732817 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.71111819 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.71049247 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.70262782 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69663939 |
| 96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69663939 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69643087 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.69615399 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.69193138 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.69129052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 5.93363924 |
| 2 | MP0004147_increased_porphyrin_level | 3.36594765 |
| 3 | MP0008004_abnormal_stomach_pH | 3.03756398 |
| 4 | MP0005083_abnormal_biliary_tract | 3.01440636 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.83403773 |
| 6 | MP0005365_abnormal_bile_salt | 2.82989232 |
| 7 | MP0003724_increased_susceptibility_to | 2.59494458 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.59095739 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.59002736 |
| 10 | MP0004130_abnormal_muscle_cell | 2.55852321 |
| 11 | MP0003879_abnormal_hair_cell | 2.54029796 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.46038740 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.20773044 |
| 14 | MP0003011_delayed_dark_adaptation | 2.11349502 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.10666183 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.03575549 |
| 17 | MP0003136_yellow_coat_color | 1.93487226 |
| 18 | MP0001968_abnormal_touch/_nociception | 1.77409616 |
| 19 | MP0003195_calcinosis | 1.77106404 |
| 20 | MP0002736_abnormal_nociception_after | 1.72734614 |
| 21 | MP0005360_urolithiasis | 1.70758522 |
| 22 | MP0000230_abnormal_systemic_arterial | 1.70155021 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 1.67946281 |
| 24 | MP0004510_myositis | 1.63918740 |
| 25 | MP0003638_abnormal_response/metabolism_ | 1.61655791 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.60115990 |
| 27 | MP0008872_abnormal_physiological_respon | 1.58633634 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.47624818 |
| 29 | MP0005670_abnormal_white_adipose | 1.40271616 |
| 30 | MP0000343_altered_response_to | 1.39660803 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.38429835 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.38328195 |
| 33 | MP0002653_abnormal_ependyma_morphology | 1.37341783 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.29866186 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.27839281 |
| 36 | MP0003252_abnormal_bile_duct | 1.25605965 |
| 37 | MP0002132_abnormal_respiratory_system | 1.25237237 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.22018361 |
| 39 | MP0003878_abnormal_ear_physiology | 1.22018361 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.20522191 |
| 41 | MP0001970_abnormal_pain_threshold | 1.20509767 |
| 42 | MP0004885_abnormal_endolymph | 1.17840621 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.17359703 |
| 44 | MP0003303_peritoneal_inflammation | 1.16784593 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.16069095 |
| 46 | MP0000249_abnormal_blood_vessel | 1.15034938 |
| 47 | MP0005535_abnormal_body_temperature | 1.14600941 |
| 48 | MP0009764_decreased_sensitivity_to | 1.13078000 |
| 49 | MP0004142_abnormal_muscle_tone | 1.11516301 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.09909529 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.08084191 |
| 52 | MP0004859_abnormal_synaptic_plasticity | 1.07682752 |
| 53 | MP0001756_abnormal_urination | 1.07299286 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.06333411 |
| 55 | MP0003690_abnormal_glial_cell | 1.05998066 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.05536733 |
| 57 | MP0009745_abnormal_behavioral_response | 1.04154177 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.02224371 |
| 59 | MP0005332_abnormal_amino_acid | 1.01024477 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.00023402 |
| 61 | MP0001545_abnormal_hematopoietic_system | 0.99733256 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 0.99733256 |
| 63 | MP0002064_seizures | 0.98160810 |
| 64 | MP0002272_abnormal_nervous_system | 0.97748640 |
| 65 | MP0008874_decreased_physiological_sensi | 0.96902834 |
| 66 | MP0001905_abnormal_dopamine_level | 0.96737474 |
| 67 | MP0003828_pulmonary_edema | 0.95987099 |
| 68 | MP0005448_abnormal_energy_balance | 0.94636049 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.94377898 |
| 70 | MP0001851_eye_inflammation | 0.93189161 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.92354128 |
| 72 | MP0001663_abnormal_digestive_system | 0.89055946 |
| 73 | MP0009763_increased_sensitivity_to | 0.88842530 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.88758048 |
| 75 | MP0001486_abnormal_startle_reflex | 0.87764913 |
| 76 | MP0008569_lethality_at_weaning | 0.86597813 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.86574693 |
| 78 | MP0001664_abnormal_digestion | 0.85405486 |
| 79 | MP0005423_abnormal_somatic_nervous | 0.84943668 |
| 80 | MP0001666_abnormal_nutrient_absorption | 0.83443538 |
| 81 | MP0009643_abnormal_urine_homeostasis | 0.81690402 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 0.80085842 |
| 83 | MP0002063_abnormal_learning/memory/cond | 0.80027162 |
| 84 | MP0002971_abnormal_brown_adipose | 0.77983455 |
| 85 | MP0003635_abnormal_synaptic_transmissio | 0.77786377 |
| 86 | MP0002735_abnormal_chemical_nociception | 0.77728147 |
| 87 | MP0001501_abnormal_sleep_pattern | 0.77454482 |
| 88 | MP0003632_abnormal_nervous_system | 0.77420066 |
| 89 | MP0003329_amyloid_beta_deposits | 0.77253916 |
| 90 | MP0005410_abnormal_fertilization | 0.76850030 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.75947112 |
| 92 | MP0003631_nervous_system_phenotype | 0.75215829 |
| 93 | MP0005171_absent_coat_pigmentation | 0.75003228 |
| 94 | MP0002067_abnormal_sensory_capabilities | 0.74551401 |
| 95 | MP0004484_altered_response_of | 0.74503207 |
| 96 | MP0003633_abnormal_nervous_system | 0.73367470 |
| 97 | MP0006138_congestive_heart_failure | 0.72393969 |
| 98 | MP0001485_abnormal_pinna_reflex | 0.70487241 |
| 99 | MP0000920_abnormal_myelination | 0.69043513 |
| 100 | MP0004085_abnormal_heartbeat | 0.68946264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.74766478 |
| 2 | Menorrhagia (HP:0000132) | 8.20086894 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.55017662 |
| 4 | Purpura (HP:0000979) | 7.29079481 |
| 5 | Abnormal platelet volume (HP:0011876) | 7.07324879 |
| 6 | Petechiae (HP:0000967) | 6.68145741 |
| 7 | Poikilocytosis (HP:0004447) | 6.19091101 |
| 8 | Epistaxis (HP:0000421) | 5.96358288 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.91462616 |
| 10 | Gingival bleeding (HP:0000225) | 5.82894720 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.40679905 |
| 12 | Acanthocytosis (HP:0001927) | 4.79200954 |
| 13 | Abnormal platelet function (HP:0011869) | 4.38099622 |
| 14 | Impaired platelet aggregation (HP:0003540) | 4.38099622 |
| 15 | Joint hemorrhage (HP:0005261) | 3.95034898 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.48338936 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.45628688 |
| 18 | Xanthomatosis (HP:0000991) | 3.44928188 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 3.27852588 |
| 20 | Complement deficiency (HP:0004431) | 3.21252374 |
| 21 | Paralysis (HP:0003470) | 3.03046466 |
| 22 | Abnormal hemoglobin (HP:0011902) | 2.90957880 |
| 23 | Polycythemia (HP:0001901) | 2.83457251 |
| 24 | Abnormality of binocular vision (HP:0011514) | 2.80323931 |
| 25 | Diplopia (HP:0000651) | 2.80323931 |
| 26 | Spontaneous abortion (HP:0005268) | 2.72518992 |
| 27 | Bruising susceptibility (HP:0000978) | 2.69058695 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 2.67661210 |
| 29 | Deep venous thrombosis (HP:0002625) | 2.62814680 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.58470603 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 2.50572021 |
| 32 | Abnormal pupillary function (HP:0007686) | 2.48115270 |
| 33 | Decreased central vision (HP:0007663) | 2.48086253 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.40537732 |
| 35 | Conjunctival telangiectasia (HP:0000524) | 2.38618931 |
| 36 | Microcytic anemia (HP:0001935) | 2.38119035 |
| 37 | Polyphagia (HP:0002591) | 2.36649584 |
| 38 | Abnormality of iron homeostasis (HP:0011031) | 2.34338453 |
| 39 | Abnormality of complement system (HP:0005339) | 2.33628529 |
| 40 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.32189886 |
| 41 | Ventricular fibrillation (HP:0001663) | 2.31913811 |
| 42 | Arthropathy (HP:0003040) | 2.20241547 |
| 43 | Glomerulonephritis (HP:0000099) | 2.16391215 |
| 44 | Hypochromic anemia (HP:0001931) | 2.15255328 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13552765 |
| 46 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11565617 |
| 47 | Joint swelling (HP:0001386) | 2.10153743 |
| 48 | Reticulocytosis (HP:0001923) | 2.09659339 |
| 49 | Dyschromatopsia (HP:0007641) | 2.09585188 |
| 50 | Febrile seizures (HP:0002373) | 2.07780763 |
| 51 | Abnormal ciliary motility (HP:0012262) | 2.02609783 |
| 52 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.98153627 |
| 53 | Absent/shortened dynein arms (HP:0200106) | 1.98153627 |
| 54 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94707552 |
| 55 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.94069636 |
| 56 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.94069636 |
| 57 | Hypobetalipoproteinemia (HP:0003563) | 1.88126524 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87184903 |
| 59 | Nausea (HP:0002018) | 1.85175978 |
| 60 | Hemorrhage of the eye (HP:0011885) | 1.83939441 |
| 61 | Generalized aminoaciduria (HP:0002909) | 1.83324619 |
| 62 | Congenital stationary night blindness (HP:0007642) | 1.82773264 |
| 63 | Ileus (HP:0002595) | 1.81517865 |
| 64 | Conjugated hyperbilirubinemia (HP:0002908) | 1.81517004 |
| 65 | Hyperventilation (HP:0002883) | 1.81501636 |
| 66 | Nephritis (HP:0000123) | 1.81395320 |
| 67 | Thrombophlebitis (HP:0004418) | 1.79676661 |
| 68 | Fair hair (HP:0002286) | 1.79082470 |
| 69 | Visual hallucinations (HP:0002367) | 1.76605697 |
| 70 | Pulmonary embolism (HP:0002204) | 1.73436393 |
| 71 | Cholelithiasis (HP:0001081) | 1.72966997 |
| 72 | Increased serum ferritin (HP:0003281) | 1.72287421 |
| 73 | Postural instability (HP:0002172) | 1.71891192 |
| 74 | Osteomalacia (HP:0002749) | 1.71241679 |
| 75 | Abnormal eating behavior (HP:0100738) | 1.71208770 |
| 76 | Hyperthyroidism (HP:0000836) | 1.70616639 |
| 77 | Tinnitus (HP:0000360) | 1.69452606 |
| 78 | Rickets (HP:0002748) | 1.66430546 |
| 79 | Vertigo (HP:0002321) | 1.65311695 |
| 80 | Hyperbilirubinemia (HP:0002904) | 1.64315962 |
| 81 | Cerebral palsy (HP:0100021) | 1.62643793 |
| 82 | Metabolic alkalosis (HP:0200114) | 1.62174735 |
| 83 | Hypophosphatemic rickets (HP:0004912) | 1.61652052 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.59921441 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.59921441 |
| 86 | Clumsiness (HP:0002312) | 1.55083786 |
| 87 | Blue irides (HP:0000635) | 1.55036492 |
| 88 | Hemiplegia (HP:0002301) | 1.50817540 |
| 89 | Polydipsia (HP:0001959) | 1.50694106 |
| 90 | Abnormal drinking behavior (HP:0030082) | 1.50694106 |
| 91 | Decreased circulating renin level (HP:0003351) | 1.50332924 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 1.48456262 |
| 93 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.47284443 |
| 94 | Muscle fiber splitting (HP:0003555) | 1.46405920 |
| 95 | Abnormality of lateral ventricle (HP:0030047) | 1.45178312 |
| 96 | Generalized hypopigmentation of hair (HP:0011358) | 1.43376349 |
| 97 | Progressive cerebellar ataxia (HP:0002073) | 1.42605916 |
| 98 | Gonadal dysgenesis (HP:0000133) | 1.40780114 |
| 99 | Atonic seizures (HP:0010819) | 1.40609587 |
| 100 | Hyperalaninemia (HP:0003348) | 1.40592844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.14413169 |
| 2 | BMX | 3.03225975 |
| 3 | MYLK | 2.73836993 |
| 4 | TAOK3 | 2.35536584 |
| 5 | PTK2B | 2.28780091 |
| 6 | DAPK2 | 2.14765123 |
| 7 | ADRBK2 | 2.02597615 |
| 8 | EIF2AK1 | 1.95506874 |
| 9 | TEC | 1.93140000 |
| 10 | GRK5 | 1.93077109 |
| 11 | WNK4 | 1.92872381 |
| 12 | SYK | 1.80969149 |
| 13 | GRK6 | 1.68978437 |
| 14 | NTRK3 | 1.66180654 |
| 15 | MST4 | 1.65566255 |
| 16 | BTK | 1.60254828 |
| 17 | BMPR1B | 1.57998477 |
| 18 | PIK3CG | 1.50367701 |
| 19 | ACVR1B | 1.49873905 |
| 20 | MAPKAPK3 | 1.39438458 |
| 21 | GRK1 | 1.22771971 |
| 22 | ZAP70 | 1.20854490 |
| 23 | ERBB2 | 1.17176587 |
| 24 | WNK1 | 1.16325732 |
| 25 | SGK2 | 1.15984239 |
| 26 | MAPK13 | 1.15504607 |
| 27 | TNK2 | 1.13417041 |
| 28 | PLK2 | 1.12162988 |
| 29 | ADRBK1 | 1.10779884 |
| 30 | CAMKK2 | 1.09721539 |
| 31 | BMPR2 | 1.09336815 |
| 32 | CSF1R | 1.07688819 |
| 33 | PINK1 | 1.06712833 |
| 34 | FGR | 1.05074899 |
| 35 | SGK223 | 1.03016878 |
| 36 | SGK494 | 1.03016878 |
| 37 | MAPK15 | 1.00540292 |
| 38 | PDK1 | 1.00092467 |
| 39 | MAPK12 | 0.99777879 |
| 40 | FES | 0.99386387 |
| 41 | TNIK | 0.99187465 |
| 42 | PIK3CA | 0.98222787 |
| 43 | TLK1 | 0.96474875 |
| 44 | TXK | 0.95142161 |
| 45 | PDPK1 | 0.94708066 |
| 46 | STK3 | 0.94114840 |
| 47 | MAP2K3 | 0.93539429 |
| 48 | RET | 0.92693473 |
| 49 | PKN1 | 0.90772733 |
| 50 | HCK | 0.90520943 |
| 51 | MAP2K1 | 0.88299520 |
| 52 | EPHA4 | 0.86824832 |
| 53 | FRK | 0.86812161 |
| 54 | PAK3 | 0.85832810 |
| 55 | EPHA3 | 0.85572609 |
| 56 | PRKACG | 0.84677393 |
| 57 | CAMK1 | 0.83840133 |
| 58 | NTRK2 | 0.80924107 |
| 59 | MARK2 | 0.80863774 |
| 60 | PNCK | 0.80447757 |
| 61 | PRKD1 | 0.79989727 |
| 62 | MAP3K11 | 0.78505512 |
| 63 | MAP4K2 | 0.73557781 |
| 64 | JAK2 | 0.72514331 |
| 65 | TYRO3 | 0.70591612 |
| 66 | SGK3 | 0.70012907 |
| 67 | ILK | 0.69132561 |
| 68 | INSRR | 0.69002810 |
| 69 | LYN | 0.67809533 |
| 70 | BLK | 0.66531283 |
| 71 | MINK1 | 0.64462323 |
| 72 | DYRK1A | 0.63460780 |
| 73 | TRPM7 | 0.61444563 |
| 74 | PRKAA2 | 0.60361029 |
| 75 | PRKG1 | 0.59499199 |
| 76 | PRKCQ | 0.58492864 |
| 77 | ITK | 0.58441475 |
| 78 | PDGFRB | 0.58143453 |
| 79 | MAP2K6 | 0.55861772 |
| 80 | MAP3K2 | 0.54563650 |
| 81 | DYRK1B | 0.54151281 |
| 82 | SGK1 | 0.53592836 |
| 83 | AKT3 | 0.53276534 |
| 84 | NLK | 0.53026509 |
| 85 | PRKCG | 0.51577368 |
| 86 | CSK | 0.51523076 |
| 87 | PHKG1 | 0.49626652 |
| 88 | PHKG2 | 0.49626652 |
| 89 | PRKACA | 0.49515098 |
| 90 | DAPK3 | 0.49310871 |
| 91 | IKBKB | 0.47881317 |
| 92 | MUSK | 0.47577578 |
| 93 | CAMKK1 | 0.46799538 |
| 94 | CAMK2A | 0.46626657 |
| 95 | FYN | 0.46448822 |
| 96 | PRKCA | 0.45655655 |
| 97 | IRAK1 | 0.45030190 |
| 98 | OXSR1 | 0.43587457 |
| 99 | TIE1 | 0.41851779 |
| 100 | MAP2K4 | 0.41518204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.64655670 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 2.55419731 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.52908751 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51301339 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.51117680 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.43732088 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41089088 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21861995 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15723427 |
| 10 | Retinol metabolism_Homo sapiens_hsa00830 | 2.12117420 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.04627378 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97882733 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88312570 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.87283838 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77016999 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.73423008 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59134357 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57756458 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55436532 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.49919442 |
| 21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44506175 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.43567240 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38514827 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37859213 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35439573 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34084303 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34025549 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31568628 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.28107182 |
| 30 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.27905180 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24726838 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22317660 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17811972 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12759832 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11350932 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03311611 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99225953 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98928106 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95960806 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 0.94874298 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94135216 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91663477 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91506774 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91226502 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90131259 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88779532 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87451541 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86765987 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.83810270 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80606164 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78042327 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.77644309 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75858017 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73789498 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71152939 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70211994 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69289319 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68255133 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.66021108 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.64958261 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64544739 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64339325 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63594377 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63512864 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62267644 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61590329 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61501182 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58236010 |
| 69 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57564659 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.54665919 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53611287 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.52951443 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52308172 |
| 74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51923972 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51029713 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.49841093 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49790037 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.49251453 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48633342 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47714736 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47311721 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47270095 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45209997 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44511972 |
| 85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43181614 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42523383 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41317547 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40326573 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39762041 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38737636 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38371807 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37421253 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.36275819 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36189305 |
| 95 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33820394 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32953669 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.32775019 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32327646 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32063835 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31760371 |

